Insights into the impact of microbiota in the treatment of NAFLD/NASH and its potential as a biomarker for prognosis and diagnosis
Publisher
MDPI
Citation
Biomedicines, 9(2), 21 p.
Extent
21 páginas
635 KB
635 KB
Abstract
"Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of chronic liver illness associated with obesity and metabolic disorders, such as hypertension, dyslipidemia, or type 2 diabetes melli...
Endorsement
Review
Supplemented By
Referenced By
Usage statistics
Aug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26